The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Occurrence of HER2 amplification in EGFR-mutant lung adenocarcinoma with acquired resistence to EGFR-TKIs.
Giuseppe Altavilla
No relevant relationships to disclose
Carmela Arrigo
No relevant relationships to disclose
Chiara Tomasello
No relevant relationships to disclose
Mariacarmela Santarpia
No relevant relationships to disclose
Patrizia Mondello
No relevant relationships to disclose
Sara Benecchi
No relevant relationships to disclose
Vincenzo Pitini
No relevant relationships to disclose